Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Nuvation Bio Yönetim
Yönetim kriter kontrolleri 2/4
Nuvation Bio's CEO is David Hung, appointed in Apr 2018, has a tenure of 6.5 years. total yearly compensation is $4.32M, comprised of 13.7% salary and 86.3% bonuses, including company stock and options. directly owns 17.71% of the company’s shares, worth $135.75M. The average tenure of the management team and the board of directors is 2.3 years and 1.3 years respectively.
Anahtar bilgiler
David Hung
İcra Kurulu Başkanı
US$4.3m
Toplam tazminat
| CEO maaş yüzdesi | 13.7% |
| CEO görev süresi | 6.5yrs |
| CEO sahipliği | 17.7% |
| Yönetim ortalama görev süresi | 2.3yrs |
| Yönetim Kurulu ortalama görev süresi | 1.3yrs |
Son yönetim güncellemeleri
Recent updates
Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024
Aug 08Is Nuvation Bio (NYSE:NUVB) A Risky Investment?
Aug 07
Nuvation Bio: A Potentially Transformative Acquisition
Jun 20Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
Mar 31Nuvation: Cash Is King, Science Is An Afterthought
Oct 03We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit
Feb 14We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Nuvation Bio GAAP EPS of -$0.12 beats by $0.02
Nov 03CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$511m |
| Mar 31 2024 | n/a | n/a | -US$69m |
| Dec 31 2023 | US$4m | US$593k | -US$76m |
| Sep 30 2023 | n/a | n/a | -US$83m |
| Jun 30 2023 | n/a | n/a | -US$90m |
| Mar 31 2023 | n/a | n/a | -US$105m |
| Dec 31 2022 | US$8m | US$570k | -US$104m |
| Sep 30 2022 | n/a | n/a | -US$108m |
| Jun 30 2022 | n/a | n/a | -US$103m |
| Mar 31 2022 | n/a | n/a | -US$88m |
| Dec 31 2021 | US$5m | US$550k | -US$87m |
| Sep 30 2021 | n/a | n/a | -US$75m |
| Jun 30 2021 | n/a | n/a | -US$64m |
| Mar 31 2021 | n/a | n/a | -US$53m |
| Dec 31 2020 | US$1m | US$475k | -US$42m |
| Sep 30 2020 | n/a | n/a | -US$38m |
| Jun 30 2020 | n/a | n/a | -US$32m |
| Mar 31 2020 | n/a | n/a | -US$33m |
| Dec 31 2019 | US$364k | US$218k | -US$34m |
Tazminat ve Piyasa: David's total compensation ($USD4.32M) is above average for companies of similar size in the US market ($USD3.23M).
Tazminat ve Kazançlar: David's compensation has been consistent with company performance over the past year.
CEO
David Hung (66 yo)
6.5yrs
Görev süresi
US$4,324,280
Tazminat
Dr. David T. Hung, M.D., serves as Founder, President, Chief Executive Officer and Director at Nuvation Bio Inc since April 2018 and has been it's Chairman of the Board since September 03, 2024. He founded...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 6.5yrs | US$4.32m | 17.71% $ 135.8m | |
| Chief Scientific Officer | 5.3yrs | US$1.36m | 0% $ 0 | |
| Chief Medical Officer | 2.3yrs | US$1.34m | 0.0027% $ 20.6k | |
| VP of Finance and Principal Accounting & Financial Officer | less than a year | Veri yok | 0.0032% $ 24.3k | |
| VP of Legal & Secretary | no data | Veri yok | Veri yok | |
| Chief People Officer | 5yrs | Veri yok | 0.0032% $ 24.2k | |
| Chief Technical Operations Officer | 3.3yrs | US$3.31m | 0.0036% $ 27.4k | |
| Chief Regulatory Officer | 2.3yrs | Veri yok | Veri yok | |
| Chief Commercial Officer | less than a year | Veri yok | 0.0075% $ 57.3k | |
| CEO & Co-Founder of AnHeart Therapeutics and Director | less than a year | Veri yok | 1.68% $ 12.9m |
2.3yrs
Ortalama Görev Süresi
54yo
Ortalama Yaş
Deneyimli Yönetim: NUVB's management team is considered experienced (2.3 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 6.5yrs | US$4.32m | 17.71% $ 135.8m | |
| CEO & Co-Founder of AnHeart Therapeutics and Director | less than a year | Veri yok | 1.68% $ 12.9m | |
| Independent Director | 4yrs | US$447.77k | 0.075% $ 572.5k | |
| Independent Director | 5.2yrs | US$440.35k | 0.051% $ 394.3k | |
| Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok | |
| Independent Director | 5.3yrs | US$448.68k | 0.091% $ 696.4k | |
| Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok | |
| Lead Independent Director | 4.3yrs | US$442.60k | Veri yok | |
| Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok |
1.3yrs
Ortalama Görev Süresi
63yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: NUVB's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.